Dong-A Pharm's chairman still refuses to accept FKI head

Published: 2003-11-04 07:00:00

Updated: 2003-11-04 07:00:00

After SK Group Chairman Son Kil-seung resigned on October 30 as head of the Federation of Korean Industries over a controversy surrounding the group's alleged illegal funding of politicians, the FKI said it named Kang Shin-ho, chairman of Dong-A Pharm as an acting chairman until February 2004, in...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK